Timothy R Holzer

Eli Lilly and Company - Indianapolis / United States

Medical and Health Sciences / Pathology

AD Scientific Index ID: 4412326

-

Registration, Add Profile,
Premium Membership

Print Your Certificate

Timothy R Holzer's MOST POPULAR ARTICLES

1-) Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trialRL Gottlieb, A Nirula, P Chen, J Boscia, B Heller, J Morris, G Huhn, ...Jama 325 (7), 632-644, 20217732021

2-) Bamlanivimab plus etesevimab in mild or moderate Covid-19M Dougan, A Nirula, M Azizad, B Mocherla, RL Gottlieb, P Chen, C Hebert, ...New England Journal of Medicine 385 (15), 1382-1392, 20214122021

3-) Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and …TR Holzer, WR McMaster, JD ForneyMolecular and biochemical parasitology 146 (2), 198-218, 20062092006

4-) Global gene expression in LeishmaniaG Cohen-Freue, TR Holzer, JD Forney, WR McMasterInternational journal for parasitology 37 (10), 1077-1086, 20071652007

5-) A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancerDS Hong, R Kurzrock, Y Oh, J Wheler, A Naing, L Brail, S Callies, V André, ...Clinical Cancer Research 17 (20), 6582-6591, 20111442011

ARTICLES

Add your articles